Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

OTC Allergy Drug Use Increases: A Symptom With Multiple Causes

Mar 23 2017

• By Malcolm Spicer

Related Content

<em>Nasacort AQ</em> Switch Gets NDAC Nod Despite Pediatric Use Concerns

Aug 05 2013

Steroid Nasal Sprays Not Suitable For Rx-to-OTC Switch – Task Force

May 22 2006

OTC Allergy Drugs: Not Just For Sniffles And Headaches, Sanofi Advises

Mar 23 2017

Zyrtec Launch Brings Big Boost To Johnson & Johnson, But Competition Grows

Apr 21 2008

<em>Rhinocort</em> Switch Makes Three In OTC Intranasal Corticosteroid Market

Mar 26 2015

<em>Flonase Allergy Relief</em> Exclusivity Sliced Up By Label Carve-Out

Feb 10 2015

Sanofi’s <em>Nasacort</em> First-In-Class Switch Receives FDA Approval

Oct 11 2013

Related Companies

Sanofi

Johnson & Johnson

Perrigo Company PLC

Sanofi

GSK plc

AstraZeneca PLC

Additional Topics

United States Prescription To OTC Switch Reimbursement OTC Drugs Respiratory Consumer

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window